Deep search
Web
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
the FDA is banning red dye No. 3
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats
After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,
FDA moves to ban Red 3, citing concern over cancer in some animals
FDA officials have telegraphed the decision for months. While the agency has long said that it did not think evidence of Red 3 causing cancer applied to humans, officials said their hand was forced by a law requiring the agency to pull additives that are cancerous in animals.
FDA bans Red 3 food dye, citing cancer risk
The FDA has banned Red 3, a dye used in foods like candies and snack cakes, citing cancer risks observed in lab rats.
FDA bans red food dye due to potential cancer risk
The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary supplements and ingested medicines, as reported on Wednesday.
Why the FDA is banning red dye No. 3
The FDA said the food color additive must be removed from food by 2027. The Post's Rachel Roubein explains the reasons behind the decision and its potential impact.
Some of your favorite foods and snacks contained the banned Red Dye No. 3. Here they are
Several consumer-favorite cereals, snacks and other food products may have contained the red food coloring recently banned by the FDA.
Red Dye No. 3 versus Red 40: What is the difference, why is only one being banned?
The U.S. Food and Drug Administration banned Red No. 3 last dye, leading those to think Red Dye No. 40 could be next. How are these dyes different?
Here are the food additives and dyes you eat that could be banned next
With the recent news that the Food and Drug Administration is banning Red No. 3, the artificial dye that is considered a potential carcinogen, some experts are saying it could be the start of a much larger trend to remove any number of additives from some of our favorite foods and drinks.
Red Dye No. 3 is Banned: Here Are the Most Popular Foods Affected
While the ban on Red No. 3 certainly impacts a handful of foods and drinks, it's not as widespread as some media outlets report. Many incorrectly claim that certain flavored puddings, strawberry Pediasure,
Atara, FDA
US FDA puts clinical hold on Atara's trials for cancer cell therapies
Atara Biotherapeutics said on Tuesday the U.S. health regulator has placed a clinical hold on its trials for cancer cell therapies, sending the drug developer's shares down more than 4% in premarket trading.
Atara Biotherapeutics Faces Strategic Uncertainty Amid FDA Hold and CRL Issues
H.C. Wainwright analyst Robert Burns has reiterated their neutral stance on ATRA stock, giving a Hold rating yesterday.Invest with Confidence:
Atara extends losses after FDA clinical hold
Shares of Atara Biotherapeutics (NASDAQ:ATRA) continued to trade lower in the premarket on Tuesday after the U.S. Food and Drug Administration (FDA) slapped the cell therapy developer with a clinical hold,
STAT
13h
Pharmalittle: We’re reading about a cancer therapy’s gold rush, FDA warning Sanofi, and more news
A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...
WebMD
10h
FDA Approves New Treatment for Advanced Breast Cancer
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
BioPharma Dive
1d
AstraZeneca, Daiichi’s Enhertu successor gets first FDA OK in breast cancer
The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...
Healio
1d
FDA approves Datroway for advanced breast cancer
The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...
6d
US FDA approves Amgen's colorectal cancer therapy
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...
1d
FDA Approves AstraZeneca's Datroway For Pretreated Breast Cancer Patients
On Friday, the U.S. Food and Drug Administration (FDA) approved AstraZeneca Plc’s (NASDAQ:AZN) Datroway (datopotamab ...
clinicaladvisor.com
12h
FDA Approves Datroway for Advanced HR+, HER2- Breast Cancer
Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.
Hosted on MSN
4h
FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen
The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback